1. Home
  2. ALX vs NEO Comparison

ALX vs NEO Comparison

Compare ALX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexander's Inc.

ALX

Alexander's Inc.

HOLD

Current Price

$230.57

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$7.96

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALX
NEO
Founded
1928
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
ALX
NEO
Price
$230.57
$7.96
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$11.14
AVG Volume (30 Days)
41.7K
1.3M
Earning Date
05-04-2026
04-28-2026
Dividend Yield
7.91%
N/A
EPS Growth
N/A
N/A
EPS
5.50
N/A
Revenue
$213,183,000.00
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
$41.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$189.05
$4.72
52 Week High
$260.84
$13.74

Technical Indicators

Market Signals
Indicator
ALX
NEO
Relative Strength Index (RSI) 39.88 40.62
Support Level $229.26 $7.59
Resistance Level $235.65 $8.89
Average True Range (ATR) 6.89 0.40
MACD -1.52 0.09
Stochastic Oscillator 22.11 61.38

Price Performance

Historical Comparison
ALX
NEO

About ALX Alexander's Inc.

Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing, and redeveloping its properties. It has five properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City, which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: